HUTCHMED (China) Limited Sponsored ADR (HCM) vs Indivior Pharmaceuticals Inc. (INDV)
- HUTCHMED (China) Limited Sponsored ADR HCM 14.05 +0.79%
- Indivior Pharmaceuticals Inc. INDV 32.45 −3.48%
HUTCHMED (China) Limited Sponsored ADR and Indivior Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. Indivior Pharmaceuticals Inc. is the larger, with a market value of $4.0B against $2.4B — 1.6× the size. HUTCHMED (China) Limited Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Indivior Pharmaceuticals Inc. trades at 11.2×. HUTCHMED (China) Limited Sponsored ADR grew revenue faster over the last twelve months: 245.2% against 13.5%. Indivior Pharmaceuticals Inc. has the higher net margin (26.8% vs −23.6%) and the higher return on invested capital (460.5% vs 0.00%). Across the 17 metrics below, Indivior Pharmaceuticals Inc. leads on 9 and HUTCHMED (China) Limited Sponsored ADR on 8.
Valuation
Profitability
| Metric | HCM | INDV | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 44.40% | 81.97% | 53.94% |
| Operating margin | 0.00% | 31.56% | 0.00% |
| Net margin | (23.63%) | 26.75% | 0.00% |
| Free cash flow margin | 0.00% | (8.34%) | 0.00% |
| Return on equity | 0.00% | (153.12%) | (0.40%) |
| Return on assets | 0.00% | 26.52% | (3.32%) |
| Return on invested capital | 0.00% | 460.53% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack